Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Thumbnail

Interventional cardiologists call out ABIM for ‘unfair and unjustified’ certification policies

“This situation unacceptably exacerbates the interventional cardiology workforce shortage and threatens to directly impact the care of patients," SCAI wrote in a new statement. 

overnight night shift attending radiologist burnout

Diagnostic errors occur mostly when radiologists exceed their average daily production

It may be necessary to monitor physicians' average daily productivity numbers over more extended periods of time to address this issue. 

Thumbnail

‘Unstoppable’ radiologist keeps practicing despite millions in fines, mounting investigations

James McGuckin, MD, most recently made the news in May when the DOJ filed suit against him and his affiliated practices. 

Elon Musk Neuralink

Industry Watcher’s Digest

Buzzworthy developments of the past few days.

quotes on artificial intelligence in healthcare

Overheard this week: Notable quotes on healthcare AI

“Until there is a global consensus on how this is regulated, Asian countries—where data privacy is less of a focus—could see a clear contrast with the West in how AI is used.”

Beset with problems, radiology provider Akumin forms special committee to evaluate its strained capital structure

Its challenges have included a key imaging center shuttered by a hurricane, equipment delivery delays and problems filling positions. 

FDA announces fourth recall of 2023 for troubled heart devices

This latest recall was brought on by electrical failures and includes more than 4,500 devices. There have been 26 complaints due to the issue but no reported injuries or deaths. 

FDA highlights importance of including heart rhythm risks on drug labels

The agency has shared a new draft guidance focused on the inclusion of information related to QTc interval prolongation.